Skip to main content
logo
Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
3.080
0.00 (0.00%)
Jan 2, 2026, 9:46 AM EST - Market open

Lyra Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-32.95-93.44-62.68-55.28-43.51-22.13
Upgrade
Depreciation & Amortization
0.510.470.281.0710.1
Upgrade
Other Amortization
-0.14----
Upgrade
Loss (Gain) From Sale of Assets
-0.01-----0.05
Upgrade
Asset Writedown & Restructuring Costs
-24.721.591.32--
Upgrade
Loss (Gain) From Sale of Investments
-0.27-2.28-3.5-0.49--
Upgrade
Stock-Based Compensation
3.716.725.895.452.771.81
Upgrade
Change in Accounts Payable
-1.73-1.890.45-2.412.350.35
Upgrade
Change in Unearned Revenue
-0.6-1.53-1.563.6411.72-
Upgrade
Change in Other Net Operating Assets
-2.81-2.93-3.783.33-0.14-1.22
Upgrade
Operating Cash Flow
-34.15-70.01-63.3-43.39-25.82-21.14
Upgrade
Capital Expenditures
0.04-2.34-1.05-0.16-3.39-1.78
Upgrade
Investment in Securities
28.0782.64-11.54-64.84--
Upgrade
Investing Cash Flow
28.1380.31-12.58-65.01-3.39-1.78
Upgrade
Issuance of Common Stock
58.8269.35100.50.659.9
Upgrade
Other Financing Activities
-0.73-0.29-3.65-4.25-0.25-2.59
Upgrade
Financing Cash Flow
4.278.5365.6996.260.3687.7
Upgrade
Net Cash Flow
-1.7418.83-10.2-12.13-28.8564.79
Upgrade
Free Cash Flow
-34.11-72.35-64.35-43.55-29.21-22.92
Upgrade
Free Cash Flow Margin
-5684.50%-4716.36%-4130.36%-3195.08%-10247.37%-
Upgrade
Free Cash Flow Per Share
-23.74-55.56-64.60-72.02-112.45-133.40
Upgrade
Levered Free Cash Flow
-20.3-39-33.73-33.03-14.45-15.17
Upgrade
Unlevered Free Cash Flow
-20.3-39.14-33.73-33.03-14.45-15.17
Upgrade
Change in Working Capital
-5.15-6.35-4.894.5613.92-0.88
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q